Manhattan Associates (MANH) Cash & Equivalents (2010 - 2026)

Manhattan Associates has disclosed Cash & Equivalents across 17 years of filings, most recently posting $186.1 million for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 19.29% year-over-year to $186.1 million; the TTM figure through Jun 2026 stood at $186.1 million (down 19.29% YoY), while the FY2025 annual figure was $328.7 million, up 23.48% from the prior year.
• Cash & Equivalents came in at $186.1 million for Q2 2026 at Manhattan Associates, down from $226.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $328.7 million in Q4 2025 to a low of $153.3 million in Q2 2023.
• Average Cash & Equivalents over 5 years is $220.7 million, with a median of $214.4 million recorded in 2022.
• Year-over-year, Cash & Equivalents slipped 28.29% in 2023 and jumped 32.24% in 2024.
• Over 5 years, Cash & Equivalents stood at $225.5 million in 2022, then increased by 20.08% to $270.7 million in 2023, then retreated by 1.67% to $266.2 million in 2024, then grew by 23.48% to $328.7 million in 2025, then tumbled by 43.39% to $186.1 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $186.1 million in Q2 2026, $226.1 million in Q1 2026, and $328.7 million in Q4 2025.